<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05026424</url>
  </required_header>
  <id_info>
    <org_study_id>21.04.US.HCN</org_study_id>
    <nct_id>NCT05026424</nct_id>
  </id_info>
  <brief_title>Glycemic Response in Adults With Diabetes</brief_title>
  <official_title>Glucose and Insulin Response in Adults With Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be a randomized crossover design with oral nutrition supplement interventions.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a randomized crossover design with two oral nutrition supplement interventions.&#xD;
      The subjects will be randomized to one of two interventions on two separate study days, one&#xD;
      week apart.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2, 2021</start_date>
  <completion_date type="Actual">October 5, 2021</completion_date>
  <primary_completion_date type="Actual">September 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>This will be a randomized crossover design. The subjects will be randomized to one of two interventions on two separate study days, one week apart.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Site pharmacy will not be blinded to product assignment, study staff and participants will be blinded to product assignment. Product will be provided in unlabeled cups.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Post-prandial glycemic markers</measure>
    <time_frame>[Time Frame: Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes]</time_frame>
    <description>Area under the blood glucose curve (AUC 0-240 minutes)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-prandial insulin markers</measure>
    <time_frame>[Time Frame: Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes]</time_frame>
    <description>Area under the insulin curve (AUC 0-240 minutes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulinogenic index</measure>
    <time_frame>[Time Frame: Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes]</time_frame>
    <description>Insulinogenic index (change in Ins30/change in Glu30)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Active Comparator: Oral Nutrition Supplement Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The control study intervention is an oral drink that contain protein, carbohydrate and fat and are intended for use as supplemental nutrition.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active Comparator: Oral Nutrition Supplement Test</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The test study intervention is an oral drink that contain protein, carbohydrate and fat and are intended for use as supplemental nutrition for people living with diabetes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Balance oral nutritional drink - control</intervention_name>
    <description>Drink 1 cup of liquid nutrition product that contains protein, carbohydrate and fat intended for use as supplemental nutrition.</description>
    <arm_group_label>Active Comparator: Oral Nutrition Supplement Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Balance oral nutritional drink - test</intervention_name>
    <description>Drink 1 cup of liquid nutrition product that contains protein, carbohydrate and fat designed for people living with diabetes and intended for use as supplemental nutrition.</description>
    <arm_group_label>Active Comparator: Oral Nutrition Supplement Test</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 20-75 years&#xD;
&#xD;
          -  Type 2 diabetes controlled with diet or diet and metformin (Glucophage)&#xD;
&#xD;
          -  Hemoglobin A1C less than 9.0%&#xD;
&#xD;
          -  Fasting blood glucose less than 180 mg/dl&#xD;
&#xD;
          -  Hematocrit levels within normal limits&#xD;
&#xD;
          -  Having obtained his/her informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Abnormal thyroid function&#xD;
&#xD;
          -  Creatinine &gt;2.0 mg/dl&#xD;
&#xD;
          -  Potassium &lt;3.5 mEq/l&#xD;
&#xD;
          -  Gastrointestinal disease: ulcer, gastritis, diarrhea, gastroparesis, vomiting&#xD;
&#xD;
          -  Currently unstable diabetes or under treatment for cancer, heart disease, renal&#xD;
             disease&#xD;
&#xD;
          -  Patients with anemia&#xD;
&#xD;
          -  Current insulin therapy or insulin therapy within the past month&#xD;
&#xD;
          -  Patient who are pregnant&#xD;
&#xD;
          -  Allergies to milk, soy or any component of the test product&#xD;
&#xD;
          -  Patient who in the investigators assessment cannot be expected to comply with&#xD;
             treatment&#xD;
&#xD;
          -  Patients with anemia&#xD;
&#xD;
          -  Currently participating in another clinical trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Krysmaru Araujo Torres, MD</last_name>
    <role>Study Director</role>
    <affiliation>Nestle Health Science</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Orange County Research Center</name>
      <address>
        <city>Tustin</city>
        <state>California</state>
        <zip>92780</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>August 24, 2021</study_first_submitted>
  <study_first_submitted_qc>August 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 30, 2021</study_first_posted>
  <last_update_submitted>October 20, 2021</last_update_submitted>
  <last_update_submitted_qc>October 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

